TY - JOUR
T1 - Prospective evaluation of Roux-En-Y gastric bypass as primary operation for medically complicated obesity
AU - Balsiger, Bruno M.
AU - Kennedy, Frank P.
AU - Abu-Lebdeh, Haitham S.
AU - Collazo-Clavell, Maria
AU - Jensen, Michael D.
AU - O'Brien, Timothy
AU - Hensrud, Donald D.
AU - Dinneen, Sean F.
AU - Thompson, Geoffrey B.
AU - Que, Florencia G.
AU - Williams, Donald E.
AU - Clark, Matthew M.
AU - Grant, Jeanne E.
AU - Frick, Marsha S.
AU - Mueller, Roger A.
AU - Mai, Jane L.
AU - Sarr, Michael G.
PY - 2000
Y1 - 2000
N2 - Objective: To determine prospectively the results of Roux-en-Y gastric bypass (RYGB) used as the primary weight-reducing operation in patients with medically complicated ('morbid') obesity. The RYGB procedure combines the advantages of a restrictive physiology (pouch of 10 mL) and a 'dumping physiology' for high-energy liquids without requiring an externally reinforced (banded) stoma. Patients and Methods: Between April 1987 and December 1998, a total of 191 consecutive patients with morbid obesity (median weight, 138 kg [range, 91-240 kg]; median body mass index, 49 kg/m2 [range, 36-74 kg/m2), all of whom had directly weight-related morbidity, underwent RYGB and prospective follow-up. Results: Hospital mortality was 0.5% (1/191), and hospital morbidity occurred in 10.5% (20/191). Good longterm weight loss was achieved, and patients adapted well to the required new eating habits. The mean ± SD weight loss at 1 year after operation (113 patients) was 52±1 kg or 68%±2% of initial excess body weight. By 3 years postoperatively (74 patients), weight loss was still 66%±2% of excess body weight. Overall, 53 (72%) of 74 patients had achieved and maintained a weight loss of 50% or more of their preoperative excess body weight 3 years after the operation. In addition, only 1 (1%) of 98 patients had persistent postoperative vomiting 1 or more times per week. Conclusion: We believe that RYGB is a safe, effective procedure for most patients with morbid obesity and thus may be the current procedure of choice in patients requiring bariatric surgery for morbid obesity.
AB - Objective: To determine prospectively the results of Roux-en-Y gastric bypass (RYGB) used as the primary weight-reducing operation in patients with medically complicated ('morbid') obesity. The RYGB procedure combines the advantages of a restrictive physiology (pouch of 10 mL) and a 'dumping physiology' for high-energy liquids without requiring an externally reinforced (banded) stoma. Patients and Methods: Between April 1987 and December 1998, a total of 191 consecutive patients with morbid obesity (median weight, 138 kg [range, 91-240 kg]; median body mass index, 49 kg/m2 [range, 36-74 kg/m2), all of whom had directly weight-related morbidity, underwent RYGB and prospective follow-up. Results: Hospital mortality was 0.5% (1/191), and hospital morbidity occurred in 10.5% (20/191). Good longterm weight loss was achieved, and patients adapted well to the required new eating habits. The mean ± SD weight loss at 1 year after operation (113 patients) was 52±1 kg or 68%±2% of initial excess body weight. By 3 years postoperatively (74 patients), weight loss was still 66%±2% of excess body weight. Overall, 53 (72%) of 74 patients had achieved and maintained a weight loss of 50% or more of their preoperative excess body weight 3 years after the operation. In addition, only 1 (1%) of 98 patients had persistent postoperative vomiting 1 or more times per week. Conclusion: We believe that RYGB is a safe, effective procedure for most patients with morbid obesity and thus may be the current procedure of choice in patients requiring bariatric surgery for morbid obesity.
UR - http://www.scopus.com/inward/record.url?scp=0033938542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033938542&partnerID=8YFLogxK
U2 - 10.1016/s0025-6196(11)64612-0
DO - 10.1016/s0025-6196(11)64612-0
M3 - Article
C2 - 10907381
AN - SCOPUS:0033938542
SN - 0025-6196
VL - 75
SP - 673
EP - 680
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 7
ER -